Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.12 Insider Own3.52% Shs Outstand263.79M Perf Week-4.58%
Market Cap954.28M Forward P/E32.18 EPS next Y0.11 Insider Trans-0.71% Shs Float260.09M Perf Month-14.90%
Income-31.29M PEG- EPS next Q0.01 Inst Own51.29% Short Float / Ratio14.93% / 16.16 Perf Quarter-25.32%
Sales176.55M P/S5.41 EPS this Y87.25% Inst Trans8.23% Short Interest38.82M Perf Half Y-23.71%
Book/sh-0.93 P/B- EPS next Y353.85% ROA-10.19% Target Price6.92 Perf Year-19.73%
Cash/sh0.52 P/C6.77 EPS next 5Y35.60% ROE- 52W Range3.38 - 5.75 Perf YTD-32.83%
Dividend- P/FCF- EPS past 5Y21.35% ROI-31.25% 52W High-38.43% Beta1.49
Dividend %- Quick Ratio2.06 Sales past 5Y62.97% Gross Margin65.55% 52W Low4.89% ATR0.18
Employees395 Current Ratio2.34 Sales Q/Q56.14% Oper. Margin-5.30% RSI (14)40.78 Volatility3.03% 5.41%
OptionableYes Debt/Eq- EPS Q/Q111.49% Profit Margin-17.72% Rel Volume0.66 Prev Close3.50
ShortableYes LT Debt/Eq- EarningsNov 07 AMC Payout- Avg Volume2.40M Price3.54
Recom1.33 SMA20-4.92% SMA50-10.09% SMA200-17.64% Volume1,589,854 Change1.14%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Nov-08-23 03:27PM
Nov-07-23 09:15PM
06:15AM Loading…
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
Oct-30-23 06:15AM
Sep-07-23 07:08AM
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
12:00AM Loading…
Aug-07-23 06:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
06:00AM Loading…
May-09-23 11:30PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
Nov-08-22 04:30PM
Nov-01-22 06:00AM
Sep-29-22 11:38AM
Sep-21-22 05:00PM
Sep-19-22 06:00AM
Sep-08-22 01:18PM
Sep-06-22 06:15AM
Sep-01-22 06:00AM
Aug-25-22 09:09AM
Aug-19-22 06:18AM
Aug-16-22 09:03AM
Aug-10-22 07:19AM
Aug-09-22 05:15PM
Aug-02-22 06:00AM
Aug-01-22 07:35PM
Jul-26-22 10:13AM
Jun-20-22 09:28AM
Jun-03-22 10:00AM
May-25-22 10:16AM
May-24-22 06:00AM
May-19-22 06:00AM
May-17-22 06:06AM
May-09-22 06:00AM
May-06-22 01:30AM
May-05-22 05:25PM
May-04-22 06:15PM
Apr-28-22 06:00AM
Apr-27-22 10:35AM
Apr-21-22 10:38AM
Mar-28-22 06:05AM
Mar-22-22 06:05AM
Mar-08-22 06:05AM
MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Castagna MichaelChief Executive OfficerNov 01Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01Sale4.5710,00045,6862,496,735Aug 01 09:00 PM
Castagna MichaelChief Executive OfficerJul 03Sale4.0710,00040,7012,506,735Jul 05 06:00 AM
Castagna MichaelChief Executive OfficerJun 01Sale4.5310,00045,3022,516,735Jun 02 09:00 PM
Castagna MichaelChief Executive OfficerMay 26Sale4.5075,000337,3352,526,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 25Sale4.5975,000344,4682,601,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 24Sale4.69150,000702,7802,331,735May 24 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 24Sale4.6895,576447,754735,263May 24 09:00 PM
Binder Steven B.Chief Financial OfficerMay 24Sale4.6747,810223,512838,324May 24 09:00 PM
Castagna MichaelChief Executive OfficerMay 05Sale4.0010,00040,0002,020,128May 05 09:00 PM
Castagna MichaelChief Executive OfficerApr 03Sale4.1310,00041,2872,030,128Apr 05 09:00 PM
Castagna MichaelChief Executive OfficerMar 01Sale5.2710,00052,7482,040,128Mar 03 09:00 PM